JY
NERV icon

Jeff Yass’s Minerva Neurosciences NERV Stock Holding History

Jeff Yass’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,400
Closed -$27.7K – 13168
2022
Q4 		$27.7K Sell
17,400
-200
-1% -$865 ﹤0.01% 11648
2022
Q3 		$162K Sell
17,600
-41,800
-70% -$248K ﹤0.01% 11132
2022
Q2 		$197K Buy
59,400
+38,025
+178% +$155K ﹤0.01% 10650
2022
Q1 		$142K Sell
21,375
-525
-2% -$3.22K ﹤0.01% 11608
2021
Q4 		$140K Sell
21,900
-4,075
-16% -$38.4K ﹤0.01% 11872
2021
Q3 		$362K Buy
25,975
+11,450
+79% +$172K ﹤0.01% 10161
2021
Q2 		$270K Buy
14,525
+9,375
+182% +$202K ﹤0.01% 11006
2021
Q1 		$120K Buy
5,150
+3,662
+246% +$91.5K ﹤0.01% 11773
2020
Q4 		$28K Sell
1,488
-2,150
-59% -$54.2K ﹤0.01% 10854
2020
Q3 		$93K Sell
3,638
-1,537
-30% -$41.5K ﹤0.01% 9952
2020
Q2 		$149K Sell
5,175
-42,025
-89% -$2.47M ﹤0.01% 9269
2020
Q1 		$2.27M Buy
47,200
+44,662
+1,760% +$2.69M ﹤0.01% 3738
2019
Q4 		$144K Buy
2,538
+750
+42% +$33.1K ﹤0.01% 8964
2019
Q3 		$111K Buy
1,788
+325
+22% +$18.4K ﹤0.01% 9507
2019
Q2 		$66K Buy
+1,463
New +$73.2K ﹤0.01% 9771
2019
Q1 		– Sell
-1,438
Closed -$78K – 9495
2018
Q4 		$78K Buy
+1,438
New +$105K ﹤0.01% 8324
2018
Q3 		– Sell
-1,788
Closed -$118K – 9900
2018
Q2 		$118K Buy
+1,788
New +$109K ﹤0.01% 8973
2017
Q3 		– Sell
-13,200
Closed -$935K – 9352
2017
Q2 		$935K Buy
13,200
+11,912
+925% +$771K ﹤0.01% 5406
2017
Q1 		$83K Buy
+1,288
New +$100K ﹤0.01% 8459

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's NERV Position: Q2 2026 in Review

Jeff Yass sold out of Minerva Neurosciences (NERV) in Q2 2026, closing a stake of 119,131 shares — an estimated $718K sold.

Jeff Yass first reported a position in NERV in Q1 2016 and held it in 20 quarters. The position peaked at $1.51M in Q1 2020. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Jeff Yass reported no remaining Minerva Neurosciences position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 119,131 Minerva Neurosciences shares in Q2 2026, an estimated $718K.
  • Jeff Yass first reported a position in Minerva Neurosciences in Q1 2016 and held it in 20 quarters.
  • Jeff Yass's Minerva Neurosciences position peaked at $1.51M in Q1 2020.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.